TD Cowen reaffirms Buy rating on Cardinal Health, with analysts predicting long-term growth and guidance
From Yahoo Finance: 2025-06-16 10:50:00
Cardinal Health (NYSE:CAH) is considered one of the best 52-week high stocks to buy by analysts, with TD Cowen reiterating a Buy rating and maintaining a price target of $162 on June 10. The company is expected to increase its long-term pharmaceutical profit guidance and introduce preliminary adjusted earnings per share guidance in the range of $9.15 to $9.45.
Additionally, analysts anticipate Cardinal Health to provide insights on how other segment businesses will contribute to adjusted operating income and mention a distribution agreement with Citious Oncology to support the launch of FDA-approved immunotherapy LYMPHIR. Cardinal Health is a global healthcare company that distributes pharmaceuticals, specialty products, and medical and laboratory products.
While Cardinal Health shows potential as an investment, some believe that certain AI stocks offer greater upside potential with less downside risk. For those interested in undervalued AI stocks, a free report on the best short-term AI stock is available. No disclosure is provided in the article.